William Lee
Hepatology · Dallas, TXNPI 1043262512
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $78,209 of the $100,696 with a category attached, or 77.7%. 10 manufacturers reported payments, led by Seagen Inc. at 42.2% of the total. Reporting peaked in 2024 at $24,386 and has fallen 56.8% since, to $10,532 in 2025.
Across 46 payments — averaging $2189.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$43K
- Pfizer$25K
- GSK$23K
- E.r. Squibb & Sons, L.L.C.$3K
- Sanofi US Services Inc.$3K
- Gilead$2K
- plus $2K from 4 others
Across 248 payments — averaging $3405.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Intercept Pharmaceuticals, Inc.$336K
- AstraZeneca$176K
- E.r. Squibb & Sons, L.L.C.$92K
- Madrigal Pharmaceuticals$76K
- Novo Nordisk AS$65K
- Eiger Biopharmaceuticals, Inc.$34K
- plus $66K from 4 others
What the payments were for
- Consulting fees$78,20978%
- Speaking & faculty fees$22,05022%
- Food & beverage$4370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 12 | $42,500 |
| Pfizer | 5 | $25,075 |
| GSK | 11 | $22,629 |
| E.r. Squibb & Sons, L.L.C. | 1 | $3,225 |
| Sanofi US Services Inc. | 1 | $2,745 |
| Gilead | 1 | $2,060 |
| Alnylam Pharmaceuticals Inc. | 1 | $2,025 |
| Novo Nordisk | 12 | $272 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Stryker | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TUKYSA$20,700
- BOSULIF$3,025
- Vemlidy$2,060
- GIVLAARI$2,025
- LIVTENCITY$125
How this compares
$100,696 in reported general payments places this provider in the 75th percentile of 22 hepatology providers in Texas.
Other hepatology in Dallas
- Amit SingalDallas$534K
- Willis MaddreyDallas$289K
- Marlyn MayoDallas$67K
- Robert RahimiDallas$18K
- Gary DavisDallas$9K
- Maria Lepe-SuasteguiDallas$4K
- Ussama GhummanDallas$1K
- Sarah LieberDallas$285
- Joseph GalatiHouston$211K
- Hesham ElgouhariDenison$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.